Table 3.
Treatment Received by Stage at Diagnosis Between 2006 and 2015 in the Surveillance, Epidemiology, and End Results (SEER) Database (N = 83,883)
| Treatment | Stage I (n=64,014) | Stage II (n=5,045) | Stage III (n = 10,269) | Stage IV (n=4,555) | Total Sample (N=83,883) | p * |
|---|---|---|---|---|---|---|
|
| ||||||
| Surgically staged | <.001 | |||||
| Yes | 37,895 (59.2) | 3,693 (73.2) | 8,537 (83.1) | 1,939 (42.6) | 52,064 (62.1) | |
| No | 26,119 (40.8) | 1,352 (26.8) | 1,732 (16.9) | 2,616 (57.4) | 31,819 (37.9) | |
| TH-BSO | <.001 | |||||
| Yes | 54,871 (85.7) | 4,054 (80.4) | 8,132 (79.2) | 2,349 (51.6) | 69,406 (82.7) | |
| No | 9,143 (14.3) | 991 (19.6) | 2,137 (20.8) | 2,206 (48.4) | 14,477 (17.3) | |
| Radiation | <.001 | |||||
| Yes | 11,437 (17.9) | 3,086 (61.2) | 5,191 (50.5) | 1,056 (23.2) | 20,770 (24.8) | |
| No | 52,577 (82.1) | 1,959 (38.8) | 5,078 (49.5) | 3,499 (76.8) | 63,113 (75.2) | |
| Chemotherapy | <.001 | |||||
| Yes | 3,538 (5.5) | 861 (17.1) | 6,732 (65.6) | 3,112 (68.3) | 14,243 (17.0) | |
| No | 60,476 (94.5) | 4,184 (82.9) | 3,537 (34.4) | 1,443 (31.7) | 69,640 (83.0) | |
| Adherent treatment | <.001 | |||||
| Yes | 36,429 (56.9) | 3,825 (75.8) | 8,003 (77.9) | 1,628 (35.7) | 49,885 (59.5) | |
| No | 27,585 (43.1) | 1,220 (24.2) | 2,266 (22.1) | 2,927 (64.3) | 33,998 (40.5) | |
Data are n (%) unless otherwise specified.
TH-BSO, total hysterectomy and bilateral salpingo-oophorectomy.
*
Chi-square test for association between stage at diagnosis and treatment, all P values are two-sided.